Clinical evaluation of ascoxal a new mucolytic agent.
D000336:Aerosols / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003300:Copper / Q000627:therapeutic use*; D004837:Epinephrine / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D012129:Respiratory Function Tests; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D013183:Sputum / Q000187:drug effects; D013431:Sulfates / Q000627:therapeutic use*
D000336:Aerosols; D001639:Bicarbonates; D005100:Expectorants; D013431:Sulfates; D003300:Copper; D001205:Ascorbic Acid; D004837:Epinephrine